Crescent Biopharma, Inc. aktie
CBIO
Stängt$20.65-0.82 (-3.82%)
Laddar diagram...
Crescent Biopharma, Inc.
Market Cap
$569,420,096
Öppning21.40
Högsta22.30
Lägsta20.35
Volym419.77k
P/EN/A
Börsvärde569.42M
52 veckors högsta27.41
52 veckors lägsta8.72
Genomsnittlig volym264.6k
UtdelningN/A
BetaN/A
EPS-5.88
Om Crescent Biopharma, Inc. aktie
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
Företagsinformation
Börs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Bioteknologi
Adress:
300 Fifth Avenue
02451 Waltham, United States
02451 Waltham, United States
Telefon: + 617 460 5595
Hemsida: https://crescentbiopharma.com
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.
Anbefaling:1.11 - Stærk køb
Lägsta kursmål
22.00
↑ 6.5%
Genomsnittligt kursmål
30.29
↑ 46.7%
Median kursmål
30.00
↑ 45.3%
Högsta kursmål
35.00
↑ 69.5%